MedTrace Logo

Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 Diabetes

NCT00700765 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1531

Last updated 2016-10-28

No results posted yet for this study

Summary

This study is conducted in Asia. The aim of this observational study is to evaluate the incidence of adverse events while using Levemir® under normal clinical practice conditions.

Conditions

  • Diabetes
  • Diabetes Mellitus, Type 1
  • Diabetes Mellitus, Type 2

Interventions

DRUG

insulin detemir

For study drug, start dose and frequency of administration to be prescribed by the physician as a result of normal clinical evaluation

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2008-07-31
Completion
2008-07-31

Countries

  • Indonesia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00700765 on ClinicalTrials.gov